An appropriate test for diagnosis of gestational diabetes mellitus

Gynecological Endocrinology

Volumn 27, Issue 10, 2011, Pages 785-788

  Soheilykhah, Sedigheh ^a   Rashidi, Maryam ^a   Mojibian, Mahdieh ^a   Dara, Nahid ^a   Jafari, Fatemeh ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diagnosis; Gestational diabetes mellitus; screening

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; BLOOD GLUCOSE; COHORT STUDIES; COST SAVINGS; DIABETES, GESTATIONAL; EARLY DIAGNOSIS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; IRAN; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, SECOND; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; YOUNG ADULT;

EID: 80053900783     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.540598     Document Type: Article

References (56)

1. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller J, Kjos S, Oats J. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care 2007;30(Suppl. 2):S251
2. Jovanovic L, Pettitt DJ. Gestational diabetes mellitus. JAMA 2001;286(20):2516
3. American Diabetes Association. Standards of Medical Care in Diabetes-2009 Diabetes Care 2009;32(Suppl. 1):S13-S61
4. Soheilykhah S, Mogibian M, Rahimi-Saghand S, Rashidi M, Soheilykhah S, Piroz M. Incidence of gestational diabetes mellitus in pregnant women. Iran J Reprod Med 2010;8(1): 24-28
5. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 2002;25(10): 1862
6. Miyakoshi K, Tanaka M, Ueno K, Uehara K, Ishimoto H, Yoshimura Y. Cutoff value of 1 h, 50 g glucose challenge test for screening of gestational diabetes mellitus in a Japanese population. Diabetes Res Clin Pract, 2003;60(1):63-67
7. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2004;27(Suppl 1):S88-S90
8. American College of Obstetricians and Gynecologists Committee on Practice Bulletins, Obstetrics. ACOG Practice Bulletin: clinical management guidelines for obstetriciangynecologists: number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994): gestational diabetes. Obstet Gynecol 2001;98:525-538
9. Tanir HM, Sener T, Gnrer H, Kaya M. A ten-year gestational diabetes mellitus cohort at a university clinic of the mid- Anatolian region of Turkey. Clin exp obstetr gynecol 2005; 32(4):241
10. Punthumapol C, Tekasakul P. 50 Grams Glucose Challenge Test for Screening of Gestational Diabetes Mellitus in Each Trimester in Potential Diabetic Pregnancy. J Med Assoc Thai 2008;91(6):787-793
11. Vitoratos N, Salamalekis E, Bettas P, Kalabokis D, Chrisikopoulos A. Which is the threshold glycose value for further investigation in pregnancy? Clin exp obstetr gynecol 1997; 24(3):171
12. Juntarat W, Rueangchainikhom W, Promas S. 50-grams glucose challenge test for screening of gestational diabetes mellitus in high risk pregnancy. J Med Assoc Thailand 2007;90(4):617
13. Sun J, See L, Chiu T, Hsieh T, Huang M. An appropriate indicator for diagnosing gestational diabetes. Chang Gung Med J 2005;28(12):824
14. Atilano LC, Lee-Parritz A, Lieberman E, Cohen AP, Barbieri RL. Alternative methods of diagnosing gestational diabetes mellitus. Am J Obstetr Gynecol 1999;181(5):1158-1161
15. Kashi Z, Borzouei SH, Akha O, Moslemizadeh N, Zakeri HR, Mohammad PA, et al. Diagnostic value of fasting plasma glucose in screening of gestational diabetes mellitus. Iranian Journal of Diabetes and Lipid Disorders, 2006;6:179
16. de Aguiar LGK, de Matos HJ, de Brito Gomes M. Could fasting plasma glucose be used for screening high-risk outpatients for gestational diabetes mellitus? Diabetes Care 2001;24(5):954
17. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19:399-428
18. Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab 2008; 22:671-685
19. Winsloe C, Earl S, Dennison EM, Cooper C, Harvey NC. Early life factors in the pathogenesis of osteoporosis. Curr Osteoporos Rep 2009;7:140-144
20. Ioannidis G, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, Plumley N, Salach L, Jiwa F, Adachi JD, Papaioannou A. Optimizing care in osteoporosis: The Canadian quality circle project. BMC Musculoskelet Disord 2008;9:130
21. Lewiecki EM. Management of osteoporosis. Clin Mol Allergy 2004;2:9-19
22. Keramat A, Patwardhan B, Larijani B, Chopra A, Mithal A, Chakravarty D, Adibi H, Khosravi A. The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskelet Disord 2008;9:28-37
23. de Oliveira Ferreira N, Arthuso M, da Silva R, Pedro AO, Neto AM, Costa-Paiva L. Quality of life in women with postmenopausal osteoporosis: correlation between QUALEFFO 41 and SF-36 Maturitas 2009;20:85-90
24. Navarro MC, Sosa M, Saavedra P, Lainez P, Marrero M, Torres M, Medina CD. Poverty is a risk factor for osteoporotic fractures. Osteoporos Int 2009;20:393-398
25. Nayak S, Roberts MS, Greenspan SL. Factors associated with osteoporosis screening and recommendations for osteoporosis screening in older adults. J Gen InternMed 2009;24:585-591
26. Alvarez C, Alonso J, Domingo A, Regidor E. La medición de la clase social en Ciencias de la Salud: informe de un grupo de trabajo de la Sociedad Española de Epidemiología. Barcelona, Spain: SG Editores S.A.; 1995
27. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: stages of reproductive aging workshop (STRAW) Park City, Utah, July 2001 Menopause 2001;8:402-407
28. Kupperman HS, Wetcheler BB, Blat MH. Contemporary therapy of the menopausal syndrome. JAMA 1959;171: 1627-1637
29. Blotman F, Cortet B, Hilliquin P, Avouac B, Allaert FA, Pouchain D, Gaudin AF, CottÕ FE, Hasnaoui A. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare. Drugs Aging 2007;24:603-614
30. Dumitrescu B, Van Helden S, Ten Broeke R, Nieuwenhuijzen- Kruseman A, Wyers C, Udrea G, van der Linden S, Geusens P. Evaluation of patients with clinical fracture and osteoporosis, a multidisciplinary approach. BMC Musculoskelet Disord 2008;9:109-119
31. Rentero ML, Carbonell C, Casillas M, González M, Berenguer R. Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: a questionnaire. Open Rheumatol J 2008;2:58-63
32. Chen JS, Hogan C, Lyubomirsky G, Sambrook PN. Management of osteoporosis in primary care in Australia. Osteoporos Int 2009;20:491-496
33. Czerwiń ski E, Badurski JE, Marcinowska-Suchowierska E, Osieleniec J. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation. Ortop Traumatol Rehabil 2007;9:337-356
34. Perreault S, Dragomir A, Blais L, Moride Y, Rossignol M, Ste-Marie LG, Fernandes JC. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture. Pharmacoepidemiol Drug Saf 2008;17: 248-259
35. Coutinho SF, Fletcher A, Bloch V, Rodrigues C. Risk factors for falls with severe fracture in elderly people living in a middle-income country: a case control study. BMC Geriatr 2008;8:21-27
36. Basset JH, Ó Shea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PG,Weiss RE, Roux JP,Malaval L, Clement-Lacroix P, Samarut J, Chassaude O, Willians GR. Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol 2007;21:1095-1107
37. Takkouche B, Montes-Martínez A, Gill SS, Etminan M. Psychotropic medications and the risk of fracture: a metaanalysis. Drug Saf 2007;30:171-184
38. Goldhahn J, Little D, Mitchell P, Fazzalari NL, Reid IR, Aspenberg P, Marsh D. ISFR working group drugs and fracture repair. Evidence for anti-osteoporosis therapy in acute fracture situations-recommendations of a multidisciplinary workshop of the International Society for Fracture Repair. Bone 2010;46:267-271
39. Kok C, Sambrook PN. Secondary osteoporosis in patients with an osteoporotic fracture. Best Pract Res Clin Rheumatol 2009;23:769-779
40. Franco CB, Paz-Filho G, Gomes PE, Nascimento VB, Kulak CA, Boguszewski CL, Borba VZ. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 2009;20:1881-1887
41. Sosa M, Saavedra P, Jódar E, Lozano-Tonkin C, Quesada JM, Torrijos A, Pérez-Cano R, Nogués X, Díaz-Curriel M, Moro MJ, Gómez C, Mosquera J, et al. Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study. Aging Clin Exp Res 2009;21:27-32
42. Williams GR. Actions of thyroid hormones in bone. Endokrynol Pol 2009;60:380-388
43. Nampei A, Hashimoto J, Koyanagi J, Ono T, Hashimoto H, Tsumaki N, Tomita T, Sugamoto K, Nishimoto N, Ochi T, Yoshikawa H. Characteristics of fracture and related factors in patients with rheumatoid arthritis. Mod Rheumatol 2008;18:170-176
44. Bischoff L, Derk CT. Premenopausal osteoporosis. Minerva Med 2008;99:55-63
45. Alexander JL, Dennerstein L, Woods NF, Halbreich V, Kotz K, Richardson G, Graziottin A, Shermann JJ. Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosis. Expert Rev Neurother 2007;7(11 Suppl):S15-S26
46. Freeman EX, Sammel MD, Lin H, Gracia CR, Pieu GW, Nelson DB, Sheng L. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007;110:230-240
47. Vondracek SF, Hansen LB, McDermott MT. Osteoporosis risk in premenopausal women. Pharmacotherapy 2009;29: 305-317
48. Gemalmaz A, Discigil G, Sensoy N, Basak O. Identifying osteoporosis in a primary care setting with quantitative ultrasound: relationship to anthropometric and lifestyle factors. J Bone Miner Metab 2007;25:184-192
49. Díez-Pérez A, González-Macías J, Marin F, Abizanda M, Alvarez R, Gimeno A, Pegenaute E, Vila J. Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporosis Int 2007;18:629-639
50. Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 2009;339:b4229
51. Malik P, Gasser RW, Kemmler G, Moncayo R, Finkenstedt G, Kurz M, Fleischhacker WW. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol 2009;33:375-381
52. Gast GC, Grobbee DE, Pop VJ, Keyzer JJ, Wijnands-van Gent CJ, Samsioe GN, Nilsson PM, van der Schouw YT. Vasomotor symptoms are associated with a lower bone mineral density. Menopause 2009;16:231-238
53. Crandall CJ, Zhen Y, Crawford SL, Thurston RC, Gold EB, Johnston JM, et al. Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause 2009;16:239-246
54. Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes. JAMA 2004;291: 1610-1620
55. Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaidis C, Walker M, Humphrey L. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057-2071
56. Siris ES, Baim S, Nattiv A. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Postgrad Med 2010; 122:82-90.